Experiences with
Imodium2,943 public posts
Want to take advantage of all our features? Just log in!
or
Managing the cardiovascular risk of Bruton's Tyrosine Kinase Inhibitors in chronic lymphocytic leukemia
The American Society of Hematology journal [i]Blood Advances[/i] published an important "[i]International Consensus Statement on the Management of Cardiovascular Risk of Bruton's Tyrosine Kinase Inhibitors in CLL[/i]" on 5 July 2022.
It provides "[i]a management guideline for CV[/i] [i]toxicities of
Thyroid Hormone Transporters in a Human Placental Cell Model
There has long been the received wisdom that T3 does not cross the placenta. I am not aware this has been proved in any level of detail.
This paper appears to make that look wrong.
Indeed, it appears to identify specific pharmaceutical agents which directly and significantly affect T3 transport